Ladenburg Thalmann Financial Services’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Hold
0
– – – 5481
2019
Q3
– Hold
0
– – – 5425
2019
Q2
– Hold
0
– – – 5385
2019
Q1
– Sell
-3
Closed -$209 – 5314
2018
Q4
$0 Hold
3
– – ﹤0.01% 5316
2018
Q3
$0 Hold
3
– – ﹤0.01% 5291
2018
Q2
$0 Hold
3
– – ﹤0.01% 5140
2018
Q1
$0 Buy
3
+2
+200% +$571 ﹤0.01% 5186
2017
Q4
$0 Hold
1
– – ﹤0.01% 5103
2017
Q3
$0 Hold
1
– – ﹤0.01% 5008
2017
Q2
$0 Hold
1
– – ﹤0.01% 4951
2017
Q1
$0 Buy
+1
New +$1.66K ﹤0.01% 4952
2016
Q4
– Hold
0
– – – 4701

Other funds holding SLS

Ladenburg Thalmann Financial Services's SLS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its SELLAS Life Sciences (SLS) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5481.

Ladenburg Thalmann Financial Services first reported a position in SLS in Q1 2017 and has held it in 8 quarters since. The position peaked at $0 in Q4 2018. 11 funds tracked by Wall St. Rank hold SLS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 0 shares of SELLAS Life Sciences worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its SELLAS Life Sciences share count unchanged in Q4 2019.
  • SELLAS Life Sciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5481 holding.
  • Ladenburg Thalmann Financial Services first reported a position in SELLAS Life Sciences in Q1 2017 and has held it in 8 quarters since.
  • Ladenburg Thalmann Financial Services's SELLAS Life Sciences position peaked at $0 in Q4 2018.
  • 11 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.